RdC regimen

Jump to navigation Jump to search

WikiDoc Resources for RdC regimen

Articles

Most recent articles on RdC regimen

Most cited articles on RdC regimen

Review articles on RdC regimen

Articles on RdC regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on RdC regimen

Images of RdC regimen

Photos of RdC regimen

Podcasts & MP3s on RdC regimen

Videos on RdC regimen

Evidence Based Medicine

Cochrane Collaboration on RdC regimen

Bandolier on RdC regimen

TRIP on RdC regimen

Clinical Trials

Ongoing Trials on RdC regimen at Clinical Trials.gov

Trial results on RdC regimen

Clinical Trials on RdC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on RdC regimen

NICE Guidance on RdC regimen

NHS PRODIGY Guidance

FDA on RdC regimen

CDC on RdC regimen

Books

Books on RdC regimen

News

RdC regimen in the news

Be alerted to news on RdC regimen

News trends on RdC regimen

Commentary

Blogs on RdC regimen

Definitions

Definitions of RdC regimen

Patient Resources / Community

Patient resources on RdC regimen

Discussion groups on RdC regimen

Patient Handouts on RdC regimen

Directions to Hospitals Treating RdC regimen

Risk calculators and risk factors for RdC regimen

Healthcare Provider Resources

Symptoms of RdC regimen

Causes & Risk Factors for RdC regimen

Diagnostic studies for RdC regimen

Treatment of RdC regimen

Continuing Medical Education (CME)

CME Programs on RdC regimen

International

RdC regimen en Espanol

RdC regimen en Francais

Business

RdC regimen in the Marketplace

Patents on RdC regimen

Experimental / Informatics

List of terms related to RdC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

RdC regimen refers to a regimen consisting of Lenalidomide (Revlimid), dexamethasone, Cyclophosphamide used to treat AL amyloidosis.[1]

Regimen

RRevlimid (Lenalidomide)

ddexamethasone

CCyclophosphamide

Indications

References

  1. 1.0 1.1 Kastritis E, Terpos E, Roussou M, Gavriatopoulou M, Pamboukas C, Boletis I; et al. (2012). "A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis". Blood. 119 (23): 5384–90. doi:10.1182/blood-2011-12-396903. PMID 22517904.